Douglass B. Given
Dr. Douglass Given is an internist and infectious diseases doctor with a PhD in virology, a serial entrepreneur and a venture capitalist. He is currently the CEO of Health2047, a Silicon Valley-based integrated innovation company whose founding investor and partner is the AMA. Health2047 is working to transform healthcare at the system level by bridging the gap that exists between technology providers and the medical community.
Over the course of his career, Dr. Given has developed deep expertise in biotechnology, biopharmaceuticals, specialty medical products and healthcare innovation. He has directly participated in the development of more than 15 top-selling drugs, biologics, diagnostics, imaging agents, and medical devices. Dr. Given was involved in R&D portfolio management at Lilly, was responsible for integrating the Searle acquisition at Monsanto, chaired one of six therapeutic area development teams at Schering Plough, and led Mallinckrodt’s corporate research and venture LP investments. Immediately prior to joining Health2047, he spent more than a decade as a partner at life sciences investor Bay City Capital.
Dr. Given was also a clinical and research fellow in internal medicine and infectious diseases at Mass General Hospital and Harvard Medical School. He is a noted philanthropist and mentor, advising and sponsoring entrepreneurial programs and innovation funds at leading institutions like the University of Chicago, Wharton, Johns Hopkins, USC, the University of Texas and Houston Methodist Research Institute. Additionally, Dr. Given assists leading universities on the public health front and serves as an advisor to the Harvard School of Public Health, the Stanford Medicine Community Council and the Johns Hopkins Bloomberg School of Public Health.